Friedewald formula. As for the accuracy of calculation methods, TG/5 agreed best with the direct assay for TG concentrations ≤99 mg/dl and TG/4.5 was best for TG concentrations of 100-249 mg/dl. For TG concentrations ≥250 mg/dl, TG/5 most closely matched the measured LDLC and gave the smallest mean percent errors, but with increasingly large estimation errors as TG increased. As for the accuracy of calculation methods according to lipidemic type, TG/5 was the best estimating term for normolipidemics (TC ≤ 2 1 9 m g / d l a n d T G ≤ 1 4 9 m g / d l ) a n d hypertriglyceridemics (TC ≤219 mg/dl and TG ≥150 mg/ dl), but the percentages of samples correctly estimated decreased with increasing TG concentrations. These results suggest that the original Friedewald formula, with the term TG/5, is reasonably well classified at TG concentrations ≤99 mg/dl or in normolipidemics, but the potential for significant estimation errors steadily increases with increasing TG concentrations. We conclude that direct LDLC assay such as the Ngeneous method is a useful tool in the diagnosis and management of hypercholesterolemics, especially for those with increased TG. (J Occup Health 2000; 42: 130-137) 
Friedewald formula. As for the accuracy of calculation methods, TG/5 agreed best with the direct assay for TG concentrations ≤99 mg/dl and TG/4.5 was best for TG concentrations of 100-249 mg/dl. For TG concentrations ≥250 mg/dl, TG/5 most closely matched the measured LDLC and gave the smallest mean percent errors, but with increasingly large estimation errors as TG increased. As for the accuracy of calculation methods according to lipidemic type, TG/5 was the best estimating term for normolipidemics (TC ≤ 2 1 9 m g / d l a n d T G ≤ 1 4 9 m g / d l ) a n d hypertriglyceridemics (TC ≤219 mg/dl and TG ≥150 mg/ dl), but the percentages of samples correctly estimated decreased with increasing TG concentrations. These results suggest that the original Friedewald formula, with the term TG/5, is reasonably well classified at TG concentrations ≤99 mg/dl or in normolipidemics, but the potential for significant estimation errors steadily increases with increasing TG concentrations. We conclude that direct LDLC assay such as the Ngeneous method is a useful tool in the diagnosis and management of hypercholesterolemics, especially for those with increased TG. Low-density lipoprotein (LDL) cholesterol (LDLC) is a well-established risk factor in coronary heart disease (CHD) [1] [2] [3] . Several studies have also shown that when high LDLC concentrations are decreased by means of diet and drugs, the subsequent incidence of CHD is diminished [4] [5] [6] [7] [8] . Therefore, the Adult Treatment Panel of the National Cholesterol Education Program (NCEP) has affirmed that decisions to treat high blood cholesterol must be primarily based on the concentration of LDLC 9) . When the total cholesterol (TC) concentration exceeds 240 mg/dl, or when it exceeds 200 mg/dl and two or more other CHD risk factors are present, NCEP has recommended further lipoprotein testing to determine the concentration of LDLC. LDLC then turns out to be the basis for definitive dietary and drug treatment.
In most clinical laboratories, LDLC is currently estimated from the Friedewald formula [LDLC=TC -high-density lipoprotein (HDL) cholesterol (HDLC) -triglycerides (TG)/5 10) ], although alternative terms such as TG/6 1) instead of TG/5 have also been used to estimate the very-low-density lipoprotein (VLDL) cholesterol (VLDLC), and the estimated LDLC is practically used in many epidemiologic and clinical studies. Calculation methods assume a constant cholesterol/triglyceride ratio in the VLDL particles. The validity of calculated LDLC values therefore does not depend on the accuracy of a sole direct assay, but rather on the accuracy of three other assays (TC, HDLC, and TG) with a mathematical calculation formula that estimates the amount of cholesterol in VLDLs, but it has been reported that at higher triglyceride levels, this ratio tends to decrease, rendering the original formula inaccurate 11, 12) . In the present paper, with the direct N-geneous LDLC assay 13) , we describe the results of a comparison between the direct method and the conventional clinical methods for determining serum LDLC in middle-aged Japanese men.
Material and Methods
A survey to evaluate calculated values for LDLC was conducted in 1999 for the employees of T Corporation, which is one of the biggest building contractors in Osaka, Japan. The participants in the 1999 survey consisted of 1953 Japanese male office workers aged 30-59 yr, and the participation rate was 99.9%.
Fasting blood samples were obtained for measurements of the TC, HDLC, TG, and LDLC levels. The participants were requested to fast for 12 h and to avoid smoking and heavy physical activity for more than 2 h before the examinations. Concentrations of TC, HDLC and TG were determined enzymatically in an Olympus AU-5200 auto analyzer (Olympus Japan Co., Ltd., Tokyo, Japan) by FALCO Biosystems Co., Ltd., Tokyo, Japan. Quality control of the laboratory was maintained by an internal method, and the coefficients of variation were all within 3% for TC, HDLC and TG. To measure the LDLC concentration directly, the direct N-geneous LDLC assay 13) , which has met the NCEP Laboratory Standardization Panel analytical performance criteria (< ± 4% imprecision and < ± 4% bias),was performed according to the manufacturer's specifications in an Olympus AU-5200 auto analyzer. The assay was available from Equal Diagnostics, Exton, PA (cat. no. 7120). After Reagent 1 is mixed with the serum specimen, Detergent 1 specifically disrupts non-LDL lipoproteins and causes the release of cholesterol. The free cholesterol formed, a result of hydrolysis by cholesterol esterase, reacts with cholesterol oxidase, generating hydrogen peroxide. The latter is consumed by a peroxidase in the presence of 4-aminoantipyrine to generate a colorless product. On the addition of Reagent 2, Detergent 2 specifically releases cholesterol from LDL particles. A similar enzymatic reaction to that described above occurs, except for hydrogen peroxide, which reacts with N,N'-bis-(4-sulfobutyl)-m-toluidine disodium salt, to generate a colored product. The intensity of the color generated is proportional to the concentration of LDLC. The assay was calibrated daily with the calibrators provided (cat. no. 7272; LDLC concentrations of 0 and 113 mg/dl).
In addition, LDLC concentrations were estimated by seven different calculation formulas: (a) the method of Friedewald et al. 10) , where LDLC=TC -HDLC -TG/5; (b) the method of DeLong et al. 1) with the same formula, except that TG/6 is used in place of TG/5; and by use of the same formula, but with (c) TG/4, (d) TG/4.5, (e) TG/ 5.5, (f) TG/7, or (g) TG/8 12) . The percentage variation (V) between the estimated LDLC and the measured (direct N-geneous LDL cholesterol assay) LDLC (C e and C d , respectively) was calculated as V=(C e -C d ) × 100/Cd.
Data analysis was performed with the SPSS/PC statistical package (Marija J. Norusis, SPSS Inc., Chicago, IL, USA). Analyses of the relationships between the various calculated estimations of LDLC and the concentrations determined by the direct N-geneous LDLC method were done by the least-squares linear regression method. Paired t-test analyses were used to compare the significance of differences between the estimated LDLC and the measured LDLC. All reported p-values are twotailed, and the level of significance is p<0.05. Table 1 shows the results for the estimated LDLC by the Friedewald formula compared with the measured LDLC by the homogeneous enzymatic method. Linear regression analyses showed a high correlation of each estimated LDLC with the measured LDLC (r=0.936-0.958), and the estimated LDLC by the original Friedewald formula, with the term TG/5, had the highest correlation with the measured LDLC. The mean LDLC estimated by the original Friedewald formula was 1.4 mg/dl higher than the mean measured LDLC (p<0.001), but the difference between the mean estimated LDLC and the mean measured LDLC was the smallest among these seven estimations. The comparison-of-methods plot for the homogeneous enzymatic method (x) versus the original Friedewald formula (y) demonstrated y=1.045x -4.1 of a least-squares regression equation (Fig. 1) . Table 2 shows the percentages of subjects of which LDLC by estimation differed by less than 10% from the measured concentration according to the TG level. The percentages of subjects with values within 10% of the measured values steadily decreased with increasing TG concentrations in each formula. When TG concentrations were ≤99 mg/dl, use of the term TG/5 (Friedewald) led to the highest percentages of individuals having an estimated LDLC that fell within 10% of the measured LDLC (95% for TG≤49 mg/dl and 90% for TG 50-99 mg/dl). Nevertheless, the differences in the LDLC estimated by means of the seven formulas were generally small, below the 99 mg/dl TG level. In the TG range 100-249 mg/dl, TG/4.5 gave the closest results (83% for TG 100-149 mg/dl, 79% for TG 150-199 mg/dl, and Table 3 shows the mean percent deviations of the estimated LDLC from the measured LDLC. In the range 49 mg/dl or less of TG, the lowest percent error was noted when TG/6 was used. In the range 50-99 mg/dl of TG, the lowest percent error was found with TG/5. When TG values were 100-249 mg/dl and 300-349 mg/dl, LDLC had the least errors when TG/4.5 was used. When TG values were 250-299 mg/dl or 350 mg/dl and over, TG/5 gave the smallest mean percent errors. Standard deviations of mean percent deviations of the estimated LDLC from the measured LDLC increased with increasing TG concentrations in each formula. Table 4 shows the percentages of samples for which LDLC was within 10% of the measured LDLC according to lipidemic type. Samples were divided into six subgroups for TC and TG: normolipidemics (TC≤219 mg/ dl, TG≤149 mg/dl), hypercholesterolemics (TC≥220 mg/ dl, TG≤149 mg/dl), hypertriglyceridemics (TC≤219 mg/ dl, TG 150-249 mg/dl and TC≤219 mg/dl, TG≥250 mg/ dl), and "combined" hyperlipidemics (TC≥220 mg/dl, TG 150-249 mg/dl and TC≥220, TG≥250 mg/dl). The best estimating formula for normolipidemics was TG/5, with 88% having estimated LDLC values within 10% of the measured values. Hypercholesterolemics had an estimation accuracy rate of 89% with the term TG/4. Hypertriglyceridemics with TG 150-249 mg/dl had an estimation accuracy rate of 71% with the term TG/5. For hypertriglyceridemics with TG≥250 mg/dl, the best estimated formula was TG/5, with only 44% of subjects correctly estimated. Combined hyperlipidemics with TG values of 150-249 mg/dl were correctly estimated in 84% of cases with TG/4 and TG/4.5; for those with TG≥250 mg/dl, 55% were correctly estimated with the term TG/ 5.5. Table 5 shows the percentages of values classified correctly for estimated vs measured LDLC concentrations in the three sub-classes according to TG concentrations. Regardless of TG concentrations, samples with the lowest (≤119 mg/dl) measured LDLC were best classified with a low estimating formula (i.e., use of TG/4) and, conversely, for those with the highest (≥l60 mg/dl) measured values, best classification with a high estimating formula (i.e., use of TG/8). Subjects with measured LDLC values in the middle range of 120-159 mg/dl had the possibility of being misclassified bidirectionally.
Results

Discussion
In this study, linear regression analyses showed a high correlation for each estimated LDLC with the measured LDLC (r=0.936-0.958). As for the accuracy of calculation methods, the proportion of samples falling within the fairly broad 10% range decreased continuously with increasing TG concentrations, irrespective of the calculation factor used. Variability became noticeable at TG concentrations ≥250 mg/dl, and at least 41% of individuals had an estimated LDLC that deviated from the measured values by more than 10% at 250-299 mg/ dl TG concentrations. This percentage increased to more than 61% of individuals at TG concentrations ≥400 mg/ dl. Furthermore, the percent error and its standard deviation of the estimated LDLC from the measured LDLC steadily increased with increasing TG concentrations in each formula, so that the ability to correctly estimate the LDLC concentration varies inversely with the TG concentration.
There has been controversy as to the most accurate formula for estimating LDLC, and attempts have been made to evaluate and refine the original estimation calculations proposed by Friedewald et al. 10) to decrease potential estimation errors 1, [14] [15] [16] [17] , but the most frequently used estimation method in clinical laboratories is that of Friedewald et al. 10) In the present study, the LDLC estimated by the original Friedewald formula, with the term TG/5, had the highest correlation with the measured LDLC (r=0.958), and the difference between the mean LDLC estimated by the original Friedewald formula and the mean measured LDLC was the smallest. Furthermore, utilization of the original Friedewald formula appears to provide a reasonable alternative for individuals with TG of 99 mg/dl or less. For those with TG of 250 mg/dl or more, TG/5 is still the term that gives results most closely matching the measured LDLC, but the potential error is so great for any given individual that its use cannot be recommended.
As for the accuracy of classification of LDLC values according to lipidemic type, it was found that those with TG of 149 mg/dl or less were usually correctly estimated . Nevertheless, the correlation coefficients between LDLC estimated by means of the original Friedewald formula and the measured LDLC were 0.958, 0.962, and 0.956 for the 30-39 yr, 40-49 yr and 50-59 yr age groups, respectively. The comparison-of-methods plots for the homogeneous enzymatic method (x) versus the original Friedewald formula(y) showed least-squares regression equations of y=1.050x -4.8, y=1.046x -3.9, and y=1.043x -4.1 for the 30-39 yr, 40-49 yr and 50-59 yr age groups, respectively. These results suggest that the differences in the lipid and lipoprotein levels according to age did not greatly affect the results of this study.
Ultracentrifugation is generally regarded as the standard reference method for measuring lipoprotein levels directly. The ultracentrifugation technique depends on the accuracy of centrifugation, HDL precipitation and the cholesterol assay.
Owing to the expense and lack of availability of ultracentrifugation, methods were developed to estimate the LDLC concentration, and the estimated LDLC is practically used for the diagnosis and management of hypercholesterolemic patients, especially both in the community and at the workplace. These estimation techniques must rely on the accuracy of the TC, HDLC and TG assays, and also on an additional mathematical term that is used in an attempt to estimate the VLDLC concentration. Furthermore, it should be noted that patients adhere to 12-to 14-h fasts, because those with higher TG concentrations are in double jeopardy of being misclassified: they are subject to a higher rate of inaccurate LDLC estimation due to the increase in TG and are generally more sensitive to changes in serum TG from dietary fat intake, often requiring a longer time to return to the baseline after a meal 18, 19) . Considering that use of the Friedewald formula for estimating LDLC becomes less reliable with increasing TG concentrations and that the N-geneous LDLC assay is unaffected by increased TG and meets the established NCEP analytical performance goals, the N-geneous LDLC assay appears to be a potential screening test for hypercholesterolemia and possibly a useful tool in the management of hyperlipidemic patients.
